GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Interest Expense

Awakn Life Sciences (Awakn Life Sciences) Interest Expense : $-0.05 Mil (TTM As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Awakn Life Sciences's interest expense for the three months ended in Jan. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Awakn Life Sciences's Operating Income for the three months ended in Jan. 2024 was $ -0.63 Mil. Awakn Life Sciences's Interest Expense for the three months ended in Jan. 2024 was $ 0.00 Mil. Awakn Life Sciences has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Awakn Life Sciences Interest Expense Historical Data

The historical data trend for Awakn Life Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Interest Expense Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Interest Expense
-0.01 -0.16 -0.20 -

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.05 - - -

Awakn Life Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Awakn Life Sciences  (OTCPK:AWKNF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Awakn Life Sciences's Interest Expense for the three months ended in Jan. 2024 was $0.00 Mil. Its Operating Income for the three months ended in Jan. 2024 was $-0.63 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2024 was $0.00 Mil.

Awakn Life Sciences's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

Awakn Life Sciences had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Awakn Life Sciences (Awakn Life Sciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Interest Expense
Comparable Companies
TSXV:KNE XCNQ:BETR TSXV:XRTX XCNQ:CHGX XCNQ:DRUG TSXV:HEM XCNQ:BLAB XCNQ:TRYP TSXV:RKV TSX:AEZS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
954:Germany AWKN:Canada
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Website
https://www.awaknlifesciences.com
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines

From GuruFocus

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 06-21-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 07-01-2022

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

By PRNewswire PRNewswire • 10-11-2021

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By PurpleRose PurpleRose • 07-11-2022